2,734 Views
Adult ID
Pediatric ID
Epi/Infection Control
Investigative ID
Symposium
Helen Boucher, MD
Director, Tufts Center for Integrated Management of Antimicrobial Resistance
Tufts Medical Center
Boston, MA
Disclosure: Nothing to disclose
Vance Fowler, Jr., MD, MHS
Professor of Medicine
Duke University
Durham, North Carolina
Disclosure: Green Cross, Cubist, Cerexa, Durata, Theravance
Debiopharm: Educational fees, Other Financial or Material Support
MedImmune, Cerexa/Forest/Actavis/Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Cubist/Merck
Medical Biosurfaces
Locus
Affinergy
Contrafect
Karius
Genentech, Regeneron, Basilea: Research Grant
Pfizer, Novartis, Galderma, Novadigm, Durata, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., Cerexa, Tetraphase, Trius, MedImmune, Bayer, Theravance, Cubist, Basilea, Affinergy, Janssen, xBiotech, Contrafect, Regeneron, Basilea, Destiny.: Consultant
UpToDate: Other Financial or Material Support, Royalties
Kevin Outterson, JD, LLM
Professor & Executive Director
Boston University & CARB-X
Boston, MA
Disclosure: Nothing to disclose
Helen Boucher, MD
Director, Tufts Center for Integrated Management of Antimicrobial Resistance
Tufts Medical Center
Boston, MA
Disclosure: Nothing to disclose
Chen Yu, Dr.
Managing Partner
Vivo Capital